The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer: A meta-analysis

BACKGROUND: Panitumumab, a fully human monoclonal antibody targeting epidermal growth factor receptor, is used in combination with chemotherapy for patients with metastatic colorectal cancer (mCRC). However, the effects of panitumumab in combination with irrinotecan-based chemotherapy remain uncerta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiang, Cheng, Minjing, Wang, Zhuo, Zhao, Shipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268019/
https://www.ncbi.nlm.nih.gov/pubmed/27977573
http://dx.doi.org/10.1097/MD.0000000000005284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268019/
https://www.ncbi.nlm.nih.gov/pubmed/27977573
http://dx.doi.org/10.1097/MD.0000000000005284

Ejemplares similares